Tiffany Shearer
Acute Care · Altamonte Springs, FLNPI 1194063834
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 35.6% of the total. Reporting peaked in 2022 at $5,502 and has fallen 92.4% since, to $416 in 2025. Among acute care clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $151.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$5K
- Bristol Myers Squibb$2K
- AstraZeneca$1K
- Novocure Inc.$1K
- Novartis$964
- Gilead$379
- plus $3K from 20 others
What the payments were for
- Consulting fees$2502%
- Speaking & faculty fees$3,60027%
- Travel & lodging$1,88414%
- Food & beverage$6,46049%
- Other$9647%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 8 | $4,689 |
| Bristol Myers Squibb | 5 | $1,636 |
| AstraZeneca | 15 | $1,408 |
| Novocure Inc. | 12 | $1,191 |
| Novartis | 10 | $964 |
| Gilead(2 entities) | 3 | $379 |
| EMD Serono, Inc. | 3 | $338 |
| Incyte Corporation | 2 | $257 |
| Puma Biotechnology, Inc. | 5 | $254 |
| Sanofi | 2 | $241 |
| AbbVie | 2 | $238 |
| Seagen Inc. | 2 | $235 |
| Genentech USA, Inc. | 4 | $176 |
| GE HealthCare | 1 | $130 |
| Karyopharm Therapeutics Inc. | 1 | $125 |
| GSK | 1 | $125 |
| Melinta Therapeutics, LLC | 1 | $125 |
| Sobi, Inc | 1 | $119 |
| Merck | 1 | $117 |
| Mirati Therapeutics, Inc. | 1 | $117 |
| Eisai Inc. | 1 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $62 |
| Amgen | 1 | $57 |
| Johnson & Johnson | 2 | $34 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Grifols USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,158 in reported general payments places this provider in the 95th percentile of 1,150 acute care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Altamonte Springs
- Kimberly GrantAltamonte Springs$20K
- Melisa WilsonOrlando$214K
- Amanda PeacockJacksonville$81K
- Katrina RileyTampa$66K
- Diane GrayLake Mary$49K
- Heather RamousSafety Harbor$38K
- Melanie WeresJacksonville$37K
- Jayne JaramilloJacksonville$27K
- Melissa HamiltonTampa$23K
- Julie ElliottWinter Haven$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.